SHAREHOLDER ALERT: WeissLaw LLP Investigates Cleveland BioLabs, Inc.

NEW YORK, Oct. 21, 2020 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cleveland BioLabs, Inc. (“CBLI” or the “Company”) (NASDAQ: CBLI) in connection with the proposed merger of the Company with…

Continue Reading

HEDGE accordingly